Physician profile
Chris A Bettner
NPI 1366546764
$3,241.73
in general payments reported to CMS, 2019-2025
17 companies · $322 in 2025
The $322 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,028 · 2020: $133 · 2021: $357 · 2022: $281 · 2023: $17.41 · 2024: $103 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $442.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,940.88 | 2019-2025 | Precision7, Precision 1, Total30 |
| Johnson & Johnson Vision Care, INC. | $234.80 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $212.29 | 2021-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $159.57 | 2019-2021 | |
| Coopervision INC. | $119.97 | 2019-2022 | |
| Oyster Point Pharma, INC. | $101.51 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Bausch & Lomb Americas INC. | $97.00 | 2023-2025 | Infuse, Biotrue One Day |
| Abb Con-Cise Optical Group LLC | $91.47 | 2020-2025 | Spectacle Lenses, Contact Lens |
| Lombart Brothers, INC. | $57.54 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $57.28 | 2024-2025 | Xdemvy |
| Allergan, INC. | $33.18 | 2021-2022 | |
| Optos, INC. | $31.47 | 2019 | |
| Novartis Pharmaceuticals Corporation | $23.82 | 2021 | |
| Sun Pharmaceutical Industries INC. | $22.37 | 2021 | |
| Kala Pharmaceuticals, INC. | $20.65 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Abbvie INC. | $18.53 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Bettner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.